BOSTON SCIENTIFIC CORP (1BSX.MI) Stock Price, Forecast & Analysis
BIT:1BSX • US1011371077
1BSX.MI Key Statistics, Chart & Performance
The current stock price of 1BSX.MI is 64.4 EUR. In the past month the price decreased by -14.25%.
1BSX.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1BSX.MI.
1BSX.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1BSX.MI. While 1BSX.MI has a great profitability rating, there are some minor concerns on its financial health.
1BSX.MI Financial Highlights
Over the last trailing twelve months 1BSX.MI reported a non-GAAP Earnings per Share(EPS) of 2.59. The EPS increased by 21.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.42% | ||
| ROA | 6.54% | ||
| ROE | 11.93% | ||
| Debt/Equity | 0.48 |
1BSX.MI Forecast & Estimates
40 analysts have analysed 1BSX.MI and the average price target is 107.92 EUR. This implies a price increase of 67.58% is expected in the next year compared to the current price of 64.4.
For the next year, analysts expect an EPS growth of 14.83% and a revenue growth 11.42% for 1BSX.MI
1BSX.MI Ownership
1BSX.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 16.05 | 108.279B | ||
| 2M6 | MEDTRONIC PLC | 15.73 | 106.586B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.83 | 46.756B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.38 | 25.46B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.31 | 25.287B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.35 | 25.277B | ||
| BIM | BIOMERIEUX | 19.03 | 11.161B | ||
| DIA | DIASORIN SPA | 17.17 | 3.866B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.42 | 3.663B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.4 | 2.415B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1BSX.MI
Company Profile
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 53,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Company Info
BOSTON SCIENTIFIC CORP
300 Boston Scientific Way
Marlborough MASSACHUSETTS US
Employees: 53000
Phone: 13026365400
BOSTON SCIENTIFIC CORP / 1BSX.MI FAQ
What does BOSTON SCIENTIFIC CORP do?
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 53,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
What is the current price of 1BSX stock?
The current stock price of 1BSX.MI is 64.4 EUR. The price decreased by -17.65% in the last trading session.
Does 1BSX stock pay dividends?
1BSX.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1BSX stock?
1BSX.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for 1BSX.MI stock?
40 analysts have analysed 1BSX.MI and the average price target is 107.92 EUR. This implies a price increase of 67.58% is expected in the next year compared to the current price of 64.4.
What is the GICS sector and industry of 1BSX stock?
BOSTON SCIENTIFIC CORP (1BSX.MI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Would investing in BOSTON SCIENTIFIC CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1BSX.MI.